Unknown

Dataset Information

0

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials.


ABSTRACT:

Background

Cancer treatment-induced bone loss (CTIBL) is a frequent complication of breast cancer therapies affecting both disability and health-related quality of life (HRQoL). To date, there is still a lack of consensus about the most effective approach that would improve bone health and HRQoL. Therefore, the aim of this systematic review of randomized controlled trials (RCTs) was to summarize the evidence on the effects of antiresorptive drugs on CTIBL in patients with early breast cancer.

Methods

PubMed, Scopus, and Web of Science databases were systematically searched up to April 30, 2021 to identify RCTs satisfying the following PICO model: P) Participants: postmenopausal women with early breast cancer receiving adjuvant aromatase inhibitors (AI), age >18 years; I) Intervention: antiresorptive drugs (i.e. bisphosphonates and/or denosumab); C) Comparator: any comparator; O) Outcome: bone mineral density (BMD) modifications. Moreover, a quality assessment was performed according to the Jadad scale.

Results

Out of the initial 2415 records, 21 papers (15 studies) were included in the data synthesis. According to the Jadad scale, 6 studies obtained a score of 5, 1 study obtained a score of 4, 13 studies obtained a score of 3, and 1 study with score 1. Although both bisphosphonates and denosumab showed to increase BMD, only denosumab showed significant advantages on fractures.

Conclusions

Bone health management in patients with early breast cancer receiving adjuvant AIs remains challenging, and the optimal therapeutic approach is not standardized. Further studies are needed to investigate CTIBL, focusing on both the need for antiresorptive drugs and their duration based on individual patients' characteristics.

Systematic review registration

https://www.crd.york.ac.uk/prospero, identifier CRD42021267107.

SUBMITTER: de Sire A 

PROVIDER: S-EPMC8814453 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature

altmetric image

Publications

Efficacy of Antiresorptive Drugs on Bone Mineral Density in Post-Menopausal Women With Early Breast Cancer Receiving Adjuvant Aromatase Inhibitors: A Systematic Review of Randomized Controlled Trials.

de Sire Alessandro A   Lippi Lorenzo L   Venetis Konstantinos K   Morganti Stefania S   Sajjadi Elham E   Curci Claudio C   Ammendolia Antonio A   Criscitiello Carmen C   Fusco Nicola N   Invernizzi Marco M  

Frontiers in oncology 20220121


<h4>Background</h4>Cancer treatment-induced bone loss (CTIBL) is a frequent complication of breast cancer therapies affecting both disability and health-related quality of life (HRQoL). To date, there is still a lack of consensus about the most effective approach that would improve bone health and HRQoL. Therefore, the aim of this systematic review of randomized controlled trials (RCTs) was to summarize the evidence on the effects of antiresorptive drugs on CTIBL in patients with early breast ca  ...[more]

Similar Datasets

| S-EPMC6708609 | biostudies-literature
| S-EPMC3667516 | biostudies-other
2007-08-25 | E-GEOD-2208 | biostudies-arrayexpress
| S-EPMC11424737 | biostudies-literature
| S-EPMC8567484 | biostudies-literature
2021-04-01 | GSE161830 | GEO
| S-EPMC3853514 | biostudies-other
| S-EPMC10924380 | biostudies-literature
| S-EPMC10241086 | biostudies-literature
| S-EPMC3330223 | biostudies-literature